Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3533 |
|
| Actual shortage: | 232 (7%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3287 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850MG 50MG | TABLET | Resolved | 2024-07-05 | 2024-09-27 | 232324 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 500MG 50MG | TABLET | Resolved | 2024-07-05 | 2024-08-09 | 232328 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 1000MG 50MG | TABLET | Resolved | 2025-03-13 | 2025-06-06 | 252564 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 50MG 1000MG | TABLET | Actual shortage | 2025-07-25 | 2025-12-11 | 263574 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 50MG 1000MG | TABLET | Actual shortage | 2025-09-18 | 2025-12-11 | 267470 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 850MG 50MG | TABLET | Actual shortage | 2025-10-03 | 2025-12-11 | 268558 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 50MG 500MG | TABLET | Actual shortage | 2025-10-10 | 2025-12-11 | 269353 |
| APO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE | 500MG 50MG | TABLET | Actual shortage | 2025-12-11 | 2025-12-11 | 274185 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-16 | 2023-01-09 | 178772 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2022-12-16 | 2023-01-20 | 178775 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185967 |
| APO-SITAGLIPTIN/METFORMIN XR | 500MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185970 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185973 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185976 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185982 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-03-02 | 2024-02-02 | 185985 |
| APO-SITAGLIPTIN/METFORMIN XR | 1000MG 100MG | TABLET (EXTENDED-RELEASE) | Resolved | 2025-10-03 | 2025-10-16 | 268561 |
| APO-SITAGLIPTIN/METFORMIN XR | 50MG 1000MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2025-11-13 | 2025-11-27 | 271847 |
| APO-SOTALOL | 80MG | TABLET | Resolved | 2023-01-06 | 2023-02-16 | 180086 |
| APO-SOTALOL | 160MG | TABLET | Resolved | 2023-01-06 | 2023-02-16 | 180093 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LOSARTAN/HCTZ | 25MG 100MG | TABLET | Discontinued | 2018-09-10 | 2018-12-28 | 60997 |
| APO-LOSARTAN/HCTZ | 12.5MG 100MG | TABLET | Discontinued | 2018-11-19 | 2018-11-19 | 67146 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-MELOXICAM | 7.5MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60612 |
| APO-MEMANTINE | 10MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60615 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40781 |
| APO-METFORMIN | 500MG | TABLET | To be discontinued | 2018-02-23 | 2018-12-28 | 40784 |
| APO-METFORMIN | 500MG | TABLET | Discontinued | 2018-02-23 | 2018-11-26 | 40790 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2019-06-12 | 40778 |
| APO-METFORMIN | 850MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40796 |
| APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
| APO-METOCLOP TAB 10MG | 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1101 |
| APO-METOCLOP TAB 5MG | 5mg | tablet | Discontinued | 2017-03-13 | 2017-03-13 | 1105 |
| APO-METOPROLOL | 25MG | TABLET | To be discontinued | 2018-09-07 | 2021-06-03 | 60628 |
| APO-MYCOPHENOLATE | 250MG | CAPSULE | Discontinued | 2018-09-07 | 2018-09-15 | 60637 |
| APO-MYCOPHENOLATE | 500MG | TABLET | Discontinued | 2018-09-07 | 2018-10-12 | 60640 |
| APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
| APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
| APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
| APO-NEVIRAPINE XR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-03-11 | 2019-03-11 | 78257 |